{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:55:40Z","timestamp":1793404540898,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The effect of different dual antiplatelet therapies on thrombotic events on the background of intravascular ultrasound (IVUS) guidance is unclear. We investigated whether ticagrelor can provide any additional benefit to clopidogrel in reducing thrombotic events in acute coronary syndrome (ACS) treated with drug- eluting stent (DES), when guided by IVUS or not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 5,666 ACS patients who underwent DES implantation and who were discharged on dual antiplatelet therapy were enrolled and grouped according to the use of IVUS or not. Each group was subdivided into two subgroups according to the type of P2Y12 inhibitor used after discharge. Propensity score matching (PSM) was used between the IVUS and no-IVUS groups. Covariate adjustment of Cox proportional hazards model was used between the ticagrelor and clopidogrel groups. Thrombotic event at 12 months was compared in groups separately.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After PSM, 12-month follow-up data were available for 1,174 patients. Major adverse cardiac events (MACE) were less frequent in the IVUS-guided group (2.2% vs. 4.3%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.081) with a trend toward statistical significance. Comparison of antiplatelet regimens revealed significantly fewer major adverse cardiac and cerebrovascular events (MACCE) with ticagrelor in the entire PSM cohort and angiography-guided subgroup (2.9% vs. 5.7%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.035; 3.1% vs. 6.4%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.020, respectively). Among patients in the IVUS-guided group the outcome was comparable (2.5% vs. 4.4%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.312). Ticagrelor was associated with increasing bleeding incidence in the entire PSM cohort (1.3% vs. 3.3%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.030), mainly due to Bleeding Academic Research Consortium type 2 bleeding (0.7% vs. 2.6%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.010). The results were consistent after covariate adjustment of Cox proportional hazards model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The comparison of ischemic benefit between ticagrelor and clopidogrel was similar in patients receiving IVUS guidance during stent implantation, probably due to the precise implantation of IVUS. Multicenter, randomized studies should be performed to validate this conclusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03659-0","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T02:02:30Z","timestamp":1705543350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of ticagrelor versus clopidogrel after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome\u2014propensity score matching analysis"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4246-8317","authenticated-orcid":false,"given":"Yinan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1244-7104","authenticated-orcid":false,"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"3659_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus Clopidogrel in patients with Acute Coronary syndromes. N Engl J Med. 2009;361:1045\u201357.","journal-title":"N Engl J Med"},{"key":"3659_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.818215","author":"M Sun","year":"2022","unstructured":"Sun M, Cui W, Li L. Comparison of clinical outcomes between Ticagrelor and Clopidogrel in Acute Coronary Syndrome: a Comprehensive Meta-Analysis. Front Cardiovasc Med. 2022. https:\/\/doi.org\/10.3389\/fcvm.2021.818215.","journal-title":"Front Cardiovasc Med"},{"key":"3659_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/00015385.2018.1469371","volume":"74","author":"RA Guerbaai","year":"2019","unstructured":"Guerbaai RA, Mahata I, Mar\u00e9chaux S, le Jemtel TH, Ennezat PV. Is ticagrelor worth its high cost and side-effects? Acta Cardiol. 2019;74:93\u20138.","journal-title":"Acta Cardiol"},{"key":"3659_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.859962","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Peng W, Shi X, Han J, Wang Y, Fang Z, et al. Ticagrelor vs. Clopidogrel in older patients with Acute Coronary Syndrome undergoing percutaneous coronary intervention: insights from a Real-World Registry. Front Cardiovasc Med. 2022. https:\/\/doi.org\/10.3389\/fcvm.2022.859962.","journal-title":"Front Cardiovasc Med"},{"key":"3659_CR5","doi-asserted-by":"publisher","unstructured":"Gro Thrane P, Kris K, Olesen W, W\u20ac Urtz M, Gyldenkerne C, Madsen M et al. Effectiveness and safety of Ticagrelor implementation in patients with Acute Coronary Syndrome undergoing percutaneous coronary intervention: a Cohort Study in Western Denmark. 2022. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100301.","DOI":"10.1016\/j.lanepe.2021.100301"},{"issue":"14","key":"3659_CR6","doi-asserted-by":"publisher","first-page":"e015990","DOI":"10.1161\/JAHA.119.015990","volume":"9","author":"S V\u00f6lz","year":"2020","unstructured":"V\u00f6lz S, Petursson P, Odenstedt J, Ioanes D, Haraldsson I, Anger\u00e5s O, et al. Ticagrelor is not superior to clopidogrel in patients with acute coronary syndromes undergoing pci: a report from Swedish coronary angiography and angioplasty registry. J Am Heart Assoc. 2020;9(14):e015990.","journal-title":"J Am Heart Assoc"},{"key":"3659_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.113.003942","volume":"129","author":"B Witzenbichler","year":"2014","unstructured":"Witzenbichler B, Maehara A, Weisz G, Neumann FJ, Rinaldi MJ, Metzger DC, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation. 2014;129:463\u201370.","journal-title":"Circulation"},{"key":"3659_CR8","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.jcin.2020.04.052","volume":"13","author":"A Mentias","year":"2020","unstructured":"Mentias A, Sarrazin MV, Saad M, Panaich S, Kapadia S, Horwitz PA, et al. Long-term outcomes of coronary stenting with and without Use of Intravascular Ultrasound. JACC Cardiovasc Interv. 2020;13:1880\u201390.","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"3659_CR9","doi-asserted-by":"publisher","first-page":"e023481","DOI":"10.1161\/JAHA.121.023481","volume":"11","author":"Y Kim","year":"2022","unstructured":"Kim Y, Bae S, Johnson TW, Son NH, Sim DS, Hong YJ, et al. Role of Intravascular Ultrasound-guided percutaneous coronary intervention in optimizing outcomes in Acute Myocardial Infarction. J Am Heart Assoc. 2022;11(5):e023481.","journal-title":"J Am Heart Assoc"},{"key":"3659_CR10","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1016\/j.jacc.2018.09.013","volume":"72","author":"J Zhang","year":"2018","unstructured":"Zhang J, Gao X, Kan J, Ge Z, Han L, Lu S, et al. Intravascular Ultrasound Versus Angiography-guided drug-eluting stent implantation: the ULTIMATE Trial. J Am Coll Cardiol. 2018;72:3126\u201337.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"3659_CR11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","volume":"62","author":"ID Moussa","year":"2013","unstructured":"Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, et al. Consideration of a new definition of clinically relevant Myocardial Infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and interventions (SCAI). J Am Coll Cardiol. 2013;62(17):1563\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"3659_CR12","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao Sv, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;123:2736\u201347.","journal-title":"Circulation"},{"key":"3659_CR13","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/eurheartj\/ehq326","volume":"31","author":"KAA Fox","year":"2010","unstructured":"Fox KAA, Carruthers KF, Dunbar DR, Graham C, Manning JR, de Raedt H, et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur Heart J. 2010;31:2755\u201364.","journal-title":"Eur Heart J"},{"key":"3659_CR14","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, Bauersachs J, Dendale P, Edvardsen T, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289\u2013367.","journal-title":"Eur Heart J"},{"key":"3659_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40:87\u2013165.","journal-title":"Eur Heart J"},{"key":"3659_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2020.106828","author":"M Verdoia","year":"2021","unstructured":"Verdoia M, Savonitto S, Dudek D, Kedhi E, de Luca G. Ticagrelor as compared to conventional antiplatelet agents in coronary artery Disease: a comprehensive meta-analysis of 15 randomized trials. Vascul Pharmacol. 2021. https:\/\/doi.org\/10.1016\/j.vph.2020.106828.","journal-title":"Vascul Pharmacol"},{"key":"3659_CR17","doi-asserted-by":"publisher","unstructured":"Xi Z, Li J, Qiu H, Guo T, Wang Y, Li Y et al. Ticagrelor vs. Clopidogrel after Complex Percutaneous Coronary intervention in patients with stable coronary artery Disease.Front CardiovascMed.2021;https:\/\/doi.org\/10.3389\/fcvm.2021.768190.","DOI":"10.3389\/fcvm.2021.768190"},{"key":"3659_CR18","first-page":"320","volume":"117","author":"H Ullrich","year":"2020","unstructured":"Ullrich H, M\u00fcnzel T, Gori T. Coronary stent Thrombosis\u2014predictors and prevention. Deutsches Arzteblatt International. 2020;117:320\u20136.","journal-title":"Deutsches Arzteblatt International"},{"key":"3659_CR19","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.21037\/cdt.2020.01.15","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu J, Lo S. Fundamentals and role of intravascular ultrasound in percutaneous coronary intervention. Cardiovasc Diagnosis Therapy. 2020;10:1358\u201370.","journal-title":"Cardiovasc Diagnosis Therapy"},{"key":"3659_CR20","doi-asserted-by":"crossref","unstructured":"R\u00e4ber L, Ueki Y. Prognostic Impact of Stent Expansion Indices Following IVUS-Guided PCI: When Lumen Is Not Enough. JACC: Cardiovascular Interventions. 2021;14:1651\u20134.","DOI":"10.1016\/j.jcin.2021.06.012"},{"key":"3659_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02649-5","author":"J Tian","year":"2017","unstructured":"Tian J, Guan C, Wang W, Zhang K, Chen J, Wu Y, et al. Intravascular Ultrasound Guidance improves the long-term prognosis in patients with unprotected left main coronary artery Disease undergoing percutaneous coronary intervention. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-02649-5.","journal-title":"Sci Rep"},{"issue":"10","key":"3659_CR22","doi-asserted-by":"publisher","first-page":"e008105","DOI":"10.1161\/CIRCINTERVENTIONS.119.008105","volume":"12","author":"K Park","year":"2019","unstructured":"Park K, Cho YR, Park JS, Park TH, Kim MH, Kim YD. Comparison of the effects of Ticagrelor and Clopidogrel on Microvascular Dysfunction in patients with Acute Coronary Syndrome using Invasive Physiologic Indices. Circ Cardiovasc Interv. 2019;12(10):e008105.","journal-title":"Circ Cardiovasc Interv"},{"key":"3659_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/rb\/rby006","volume":"5","author":"J Wang","year":"2018","unstructured":"Wang J, Jin X, Huang Y, Ran X, Luo D, Yang D, et al. Endovascular stent-induced alterations in host artery mechanical environments and their roles in stent restenosis and late Thrombosis. Regen Biomater. 2018;5:177\u201387.","journal-title":"Regen Biomater"},{"key":"3659_CR24","doi-asserted-by":"publisher","first-page":"e011124","DOI":"10.1161\/CIRCINTERVENTIONS.121.011124","volume":"14","author":"YJ Lee","year":"2021","unstructured":"Lee YJ, Zhang JJ, Mintz GS, Hong SJ, Ahn CM, Kim JS, et al. Impact of Intravascular Ultrasound-guided optimal stent expansion on 3-Year hard clinical outcomes. Circ Cardiovasc Interv. 2021;14:e011124.","journal-title":"Circ Cardiovasc Interv"},{"key":"3659_CR25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","volume":"382","author":"GW Stone","year":"2013","unstructured":"Stone GW, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. The Lancet. 2013;382:614\u201323.","journal-title":"The Lancet"},{"key":"3659_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/eurheartj\/eht484","volume":"35","author":"JM Cheng","year":"2014","unstructured":"Cheng JM, Garcia-Garcia HM, de Boer SPM, Kardys I, Heo JH, Akkerhuis KM, et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J. 2014;35:639\u201347.","journal-title":"Eur Heart J"},{"key":"3659_CR27","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1093\/eurheartj\/ehz332","volume":"40","author":"TW Johnson","year":"2019","unstructured":"Johnson TW, R\u00e4ber L, di Mario C, Bourantas C, Jia H, Mattesini A, et al. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2019;40:2566\u201384.","journal-title":"Eur Heart J"},{"issue":"2","key":"3659_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2023.04.051","volume":"82","author":"F Gragnano","year":"2023","unstructured":"Gragnano F, Cao D, Pirondini L, Franzone A, Kim HS, von Scheidt M, et al. P2Y12 inhibitor or aspirin monotherapy for secondary Prevention of coronary events. J Am Coll Cardiol. 2023;82(2):89\u2013105.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03659-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03659-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03659-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T14:03:08Z","timestamp":1705586588000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03659-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3659"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03659-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3242314\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"7 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the First Affiliated Hospital of Dalian Medical University approved the study (PJ-KS-KY-2022-250).The informed consent was exempted by the ethics committee of the First Affiliated Hospital of Dalian Medical University since the study did not involve human intervention. The project number is 2022YFC2503500 and 2022YFC2503504.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"58"}}